论文部分内容阅读
目的 探讨POSSUM和APACHEⅡ评分系统对胰腺癌患者外科治疗影响的临床价值。方法 应用POSSUM和APACHEⅡ评分系统对 84例胰腺癌患者围手术期进行回顾分析。 结果 本组患者中 ,青年组 (n =36 )的病死率和并发症分别为 5 5 %和 19 4% ,老年组 (n =48)病死率和并发症分别为 6 2 %和 2 0 8% ,略低于APACHEⅡ和POSSUM评分预测的老年组病死率 (12 5 % )和并发症(2 5 5 % ) ,中青年组病死率 (11 1% )和并发症 (2 5 % )。 结论 POSSUM和APACHEⅡ能反映胰腺癌患者的病情 ,并且可影响选择最适宜的手术方式。POSSUM评分系统更适宜于指导胰腺癌手术的围手术期处理
Objective To investigate the clinical value of POSSUM and APACHE II scoring system in the surgical treatment of patients with pancreatic cancer. Methods The perioperative period of 84 patients with pancreatic cancer was retrospectively analyzed using POSSUM and APACHE II scoring system. Results In this group of patients, mortality and complications were 55% and 194% in the young group (n = 36), and 62% and 20% in the elderly group (n = 48). %, slightly lower than the APACHEII and POSSUM scores predicted in the elderly group (125%) and complications (25.5%), mortality in the young group (11%) and complications (25%). Conclusions POSSUM and APACHEII can reflect the condition of patients with pancreatic cancer and can influence the choice of the most appropriate surgical method. POSSUM scoring system is more suitable for guiding perioperative management of pancreatic cancer surgery